BlackRock Fund Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $674M | Buy |
|
|||||
|
2016
Q3 | $631M | Buy |
|
|||||
|
2016
Q2 | $533M | Buy |
|
|||||
|
2016
Q1 | $617M | Sell |
|
|||||
|
2015
Q4 | $858M | Sell |
|
|||||
|
2015
Q3 | $742M | Buy |
|
|||||
|
2015
Q2 | $855M | Buy |
|
|||||
|
2015
Q1 | $709M | Buy |
|
|||||
|
2014
Q4 | $663M | Buy |
|
|||||
|
2014
Q3 | $559M | Sell |
|
|||||
|
2014
Q2 | $645M | Sell |
|
|||||
|
2014
Q1 | $736M | Buy |
|
|||||
|
2013
Q4 | $512M | Buy |
|
|||||
|
2013
Q3 | $433M | Buy |
|
|||||
|
2013
Q2 | $325M | Buy |
|